Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota

Resveratrol (RSV) is a potential alternative therapy for non-alcoholic fatty liver disease (NAFLD) that has been evaluated in many clinical trials, but the mechanisms of RSV action have not been fully elucidated. Recent studies suggested that the gut microbiota is an important RSV target; therefore,...

Full description

Bibliographic Details
Main Authors: Fan Du, Rongfeng Huang, Dan Lin, Yuying Wang, Xiaohuang Yang, Xiaoyun Huang, Biyun Zheng, Zhixin Chen, Yuehong Huang, Xiaozhong Wang, Fenglin Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Microbiology
Subjects:
resveratrol
non-alcoholic fatty liver disease
gut microbiota
anaerobic culture
insulin resistance
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2021.611323/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2021.611323/full

Similar Items